fda panel

FDA Panel Split Over Inhaled Antipsychotic

MedPage Today Emergency Medicine  Mon, 12/12/2011 - 16:47

WASHINGTON (MedPage Today) -- An FDA advisory panel punted on the question of approval for an inhaled version of the antipsychotic drug loxapine (Adasuve) to treat agitation in bipolar and schizophrenic patients, despite the risk for respiratory side effects.


 

FDA: Stronger Labeling Needed for Newer Contraceptives

WebMD Health  Fri, 12/09/2011 - 11:34

birth control pills

An FDA panel voted 15-11 that the benefits of newer oral contraceptives outweigh their risks of dangerous blood clots.


 

FDA Panel Rejects Champion Monitor

MedPage Today Infectious Disease  Fri, 12/09/2011 - 09:00

WASHINGTON (MedPage Today) -- An FDA advisory panel overwhelmingly agreed that an implantable pulmonary artery pressure monitoring device was safe, but was not convinced about its effectiveness and benefit-risk ratio.


 

FDA Panel Votes to Expand Use of Pneumococcal Vaccine to Adults

MedPage Today Infectious Disease  Wed, 11/16/2011 - 15:43

(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted 14-1 in favor of expanding the indication for the pneumococcal 13-valent conjugate vaccine (Prevnar 13) to include use in adults 50 and older.


 

FDA Panel to Look at Pneumococcal Vax for Older Adults

MedPage Today Infectious Disease  Tue, 11/15/2011 - 11:27

WASHINGTON (MedPage Today) -- The pneumococcal 13-valent conjugate vaccine (Prevnar 13) -- currently approved only for children -- appears safe and effective at preventing pneumococcal disease in adults 50 and older, FDA reviewers concluded in advance of an advisory committee meeting Wednesday.


 

FDA Panel Unclear on Osteoporosis Drug Labels

WebMD Health  Fri, 09/09/2011 - 19:33

Graphic of femur and shin

Labels on bisphosphonates, a type of medication used to treat and prevent osteoporosis, should further clarify how long patients can take them, an FDA advisory panel voted today.


 

FDA panel backs new labels for osteoporosis drugs

Headlines from the Associated Press  Fri, 09/09/2011 - 15:06

TRENTON, N.J. (AP) -- Food and Drug Administration advisers voted Friday to require makers of widely used osteoporosis drugs to clarify how long patients should take them for the greatest benefit and least risk....


 

Medicare Will Pay for Avastin and Provenge

WebMD Health  Fri, 07/01/2011 - 14:40

Happy senior couple

Medicare will keep paying for the drug Avastin to fight breast cancer even though an FDA panel has recommended that the medication no longer be sold as a treatment for breast cancer.


 

FDA Panel Narrowly Endorses Bone Graft Device

MedPage Today Surgery  Thu, 05/12/2011 - 17:15

(MedPage Today) -- GAITHERSBURG, Md. -- An FDA advisory panel narrowly recommended approval for an investigational bone graft device that uses a growth factor protein to regrow bones in the foot and ankle.